Plasma lipid composition and risk of developing cardiovascular disease

We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Scree...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-08, Vol.8 (8), p.e71846-e71846
Hauptverfasser: Fernandez, Celine, Sandin, Marianne, Sampaio, Julio L, Almgren, Peter, Narkiewicz, Krzysztof, Hoffmann, Michal, Hedner, Thomas, Wahlstrand, Björn, Simons, Kai, Shevchenko, Andrej, James, Peter, Melander, Olle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e71846
container_issue 8
container_start_page e71846
container_title PloS one
container_volume 8
creator Fernandez, Celine
Sandin, Marianne
Sampaio, Julio L
Almgren, Peter
Narkiewicz, Krzysztof
Hoffmann, Michal
Hedner, Thomas
Wahlstrand, Björn
Simons, Kai
Shevchenko, Andrej
James, Peter
Melander, Olle
description We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Screening of the fasted plasma lipidome was performed by top-down shotgun analysis and lipidome compositions compared between incident CVD cases (n = 211) and controls (n = 216) from the prospective population-based MDC study using logistic regression adjusting for Framingham risk factors. Associations with incident CVD were seen for eight lipid species (0.21≤q≤0.23). Each standard deviation unit higher baseline levels of two lysophosphatidylcholine species (LPC), LPC16∶0 and LPC20∶4, was associated with a decreased risk for CVD (P = 0.024-0.028). Sphingomyelin (SM) 38∶2 was associated with increased odds of CVD (P = 0.057). Five triglyceride (TAG) species were associated with protection (P = 0.031-0.049). LPC16∶0 was negatively correlated with the carotid intima-media thickness (P = 0.010) and with HbA1c (P = 0.012) whereas SM38∶2 was positively correlated with LDL-cholesterol (P = 0.0*10(-6)) and the q-values were good (q≤0.03). The risk allele of 8 CAD-associated gene variants showed significant association with the plasma level of several lipid species. However, the q-values were high for many of the associations (0.015≤q≤0.75). Risk allele carriers of 3 CAD-loci had reduced level of LPC16∶0 and/or LPC 20∶4 (P≤0.056). Our study suggests that CVD development is preceded by reduced levels of LPC16∶0, LPC20∶4 and some specific TAG species and by increased levels of SM38∶2. It also indicates that certain lipid species are intermediate phenotypes between genetic susceptibility and overt CVD. But it is a preliminary study that awaits replication in a larger population because statistical significance was lost for the associations between lipid species and future cardiovascular events when correcting for multiple testing.
doi_str_mv 10.1371/journal.pone.0071846
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1430437663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478276010</galeid><doaj_id>oai_doaj_org_article_f3c1638dc78c40abb15c9feaf0729d48</doaj_id><sourcerecordid>A478276010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c865t-f2950e497ddddea1af62e2a5cf6d314d094f9fc96a770cf59c8e98680c80053e3</originalsourceid><addsrcrecordid>eNqNk21r1TAUx4sobk6_gWhBEH1xr0mT5uGNMIbTwWDi09twmocuM7epTTv125vu3o1VJpgSUk5-59_Tf3KK4ilGa0w4fnMRp6GDsO5jZ9cIcSwou1fsY0mqFasQuX_rfa94lNIFQjURjD0s9ioiGa9qsl8cfwyQNlAG33tT6rjpY_Kjj10JnSkHn76X0ZXGXtoQe9-1pYbB-HgJSU8BhtL4ZCHZx8UDByHZJ7v1oPh6_O7L0YfV6dn7k6PD05UWrB5XrpI1slRyk4cFDI5VtoJaO2YIpgZJ6qTTkgHnSLtaamGlYAJpMRdvyUHxfKvbh5jUzoKkMCWIEs4YycTJljARLlQ_-A0Mv1UEr64CcWgVDKPXwSpHNGZEGM2FpgiaBtdaOgsO8UoaKrLW6VYr_bT91CzUwtTn2eSpklVN0wB2SCrOcaWoNpWSjhCVi3eEAQgCOsut_inXZrkcaq_U8lFWNcr8293PTs3GGm27cYCwSFvudP5ctfFSEU4pZTILvNoJDPHHZNOoNj5pGwJ0Nk6zbRXnVFDMM_riL_Ruc3dUC9k_37mYv6tnUXVIuag4Q3iue30HlR9jN17n6-p8ji8SXi8SMjPaX2MLU0rq5POn_2fPvi3Zl7fYcwthPE8xTPP9TkuQbkE9xJQG625MxkjN3Xbthpq7Te26Lac9u31AN0nX7UX-AOdcJU8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1430437663</pqid></control><display><type>article</type><title>Plasma lipid composition and risk of developing cardiovascular disease</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SWEPUB Freely available online</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Fernandez, Celine ; Sandin, Marianne ; Sampaio, Julio L ; Almgren, Peter ; Narkiewicz, Krzysztof ; Hoffmann, Michal ; Hedner, Thomas ; Wahlstrand, Björn ; Simons, Kai ; Shevchenko, Andrej ; James, Peter ; Melander, Olle</creator><creatorcontrib>Fernandez, Celine ; Sandin, Marianne ; Sampaio, Julio L ; Almgren, Peter ; Narkiewicz, Krzysztof ; Hoffmann, Michal ; Hedner, Thomas ; Wahlstrand, Björn ; Simons, Kai ; Shevchenko, Andrej ; James, Peter ; Melander, Olle</creatorcontrib><description>We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Screening of the fasted plasma lipidome was performed by top-down shotgun analysis and lipidome compositions compared between incident CVD cases (n = 211) and controls (n = 216) from the prospective population-based MDC study using logistic regression adjusting for Framingham risk factors. Associations with incident CVD were seen for eight lipid species (0.21≤q≤0.23). Each standard deviation unit higher baseline levels of two lysophosphatidylcholine species (LPC), LPC16∶0 and LPC20∶4, was associated with a decreased risk for CVD (P = 0.024-0.028). Sphingomyelin (SM) 38∶2 was associated with increased odds of CVD (P = 0.057). Five triglyceride (TAG) species were associated with protection (P = 0.031-0.049). LPC16∶0 was negatively correlated with the carotid intima-media thickness (P = 0.010) and with HbA1c (P = 0.012) whereas SM38∶2 was positively correlated with LDL-cholesterol (P = 0.0*10(-6)) and the q-values were good (q≤0.03). The risk allele of 8 CAD-associated gene variants showed significant association with the plasma level of several lipid species. However, the q-values were high for many of the associations (0.015≤q≤0.75). Risk allele carriers of 3 CAD-loci had reduced level of LPC16∶0 and/or LPC 20∶4 (P≤0.056). Our study suggests that CVD development is preceded by reduced levels of LPC16∶0, LPC20∶4 and some specific TAG species and by increased levels of SM38∶2. It also indicates that certain lipid species are intermediate phenotypes between genetic susceptibility and overt CVD. But it is a preliminary study that awaits replication in a larger population because statistical significance was lost for the associations between lipid species and future cardiovascular events when correcting for multiple testing.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0071846</identifier><identifier>PMID: 23967253</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aged ; Alleles ; ARTERY-DISEASE ; ASSOCIATION ; Biology ; BIOMARKERS ; Blood cholesterol ; BLOOD-PLASMA ; Cancer ; Cardiac and Cardiovascular Systems ; Cardiology and Cardiovascular Disease ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - genetics ; Case-Control Studies ; CHOLESTEROL ; Chromatography ; Clinical Medicine ; Cluster Analysis ; Coronary artery ; Coronary artery disease ; Coronary Artery Disease - blood ; Coronary Artery Disease - epidemiology ; Coronary Artery Disease - genetics ; Coronary vessels ; CORONARY-HEART-DISEASE ; Disease susceptibility ; Endocrinology and Diabetes ; Endokrinologi och diabetes ; EVENTS ; Family medical history ; Fatalities ; Female ; Gene Expression Profiling ; Genetic aspects ; Genetic Predisposition to Disease ; Genetics ; Genomes ; Health risk assessment ; Health risks ; Heart attacks ; Heart diseases ; Humans ; Hypertension ; Kardiologi ; Kardiologi och kardiovaskulära sjukdomar ; Klinisk medicin ; Lipid composition ; Lipids ; Lipids - blood ; Lipoproteins (low density) ; Low density lipoprotein ; Low density lipoproteins ; Lysophosphatidylcholine ; Male ; Medical and Health Sciences ; Medical research ; Medicin och hälsovetenskap ; Medicine ; Metabolome ; Middle Aged ; Patient Outcome Assessment ; Plasma ; POLYMORPHISMS ; Population (statistical) ; Population studies ; PREDICTION ; Public Health Surveillance ; Regression analysis ; Risk ; Risk analysis ; Risk Factors ; SHOTGUN LIPIDOMICS ; Species ; Sphingomyelin ; Statistical analysis ; Triglycerides ; Wildlife conservation</subject><ispartof>PloS one, 2013-08, Vol.8 (8), p.e71846-e71846</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Fernandez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Fernandez et al 2013 Fernandez et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c865t-f2950e497ddddea1af62e2a5cf6d314d094f9fc96a770cf59c8e98680c80053e3</citedby><cites>FETCH-LOGICAL-c865t-f2950e497ddddea1af62e2a5cf6d314d094f9fc96a770cf59c8e98680c80053e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744469/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744469/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23967253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/184250$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/4005404$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Fernandez, Celine</creatorcontrib><creatorcontrib>Sandin, Marianne</creatorcontrib><creatorcontrib>Sampaio, Julio L</creatorcontrib><creatorcontrib>Almgren, Peter</creatorcontrib><creatorcontrib>Narkiewicz, Krzysztof</creatorcontrib><creatorcontrib>Hoffmann, Michal</creatorcontrib><creatorcontrib>Hedner, Thomas</creatorcontrib><creatorcontrib>Wahlstrand, Björn</creatorcontrib><creatorcontrib>Simons, Kai</creatorcontrib><creatorcontrib>Shevchenko, Andrej</creatorcontrib><creatorcontrib>James, Peter</creatorcontrib><creatorcontrib>Melander, Olle</creatorcontrib><title>Plasma lipid composition and risk of developing cardiovascular disease</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Screening of the fasted plasma lipidome was performed by top-down shotgun analysis and lipidome compositions compared between incident CVD cases (n = 211) and controls (n = 216) from the prospective population-based MDC study using logistic regression adjusting for Framingham risk factors. Associations with incident CVD were seen for eight lipid species (0.21≤q≤0.23). Each standard deviation unit higher baseline levels of two lysophosphatidylcholine species (LPC), LPC16∶0 and LPC20∶4, was associated with a decreased risk for CVD (P = 0.024-0.028). Sphingomyelin (SM) 38∶2 was associated with increased odds of CVD (P = 0.057). Five triglyceride (TAG) species were associated with protection (P = 0.031-0.049). LPC16∶0 was negatively correlated with the carotid intima-media thickness (P = 0.010) and with HbA1c (P = 0.012) whereas SM38∶2 was positively correlated with LDL-cholesterol (P = 0.0*10(-6)) and the q-values were good (q≤0.03). The risk allele of 8 CAD-associated gene variants showed significant association with the plasma level of several lipid species. However, the q-values were high for many of the associations (0.015≤q≤0.75). Risk allele carriers of 3 CAD-loci had reduced level of LPC16∶0 and/or LPC 20∶4 (P≤0.056). Our study suggests that CVD development is preceded by reduced levels of LPC16∶0, LPC20∶4 and some specific TAG species and by increased levels of SM38∶2. It also indicates that certain lipid species are intermediate phenotypes between genetic susceptibility and overt CVD. But it is a preliminary study that awaits replication in a larger population because statistical significance was lost for the associations between lipid species and future cardiovascular events when correcting for multiple testing.</description><subject>Aged</subject><subject>Alleles</subject><subject>ARTERY-DISEASE</subject><subject>ASSOCIATION</subject><subject>Biology</subject><subject>BIOMARKERS</subject><subject>Blood cholesterol</subject><subject>BLOOD-PLASMA</subject><subject>Cancer</subject><subject>Cardiac and Cardiovascular Systems</subject><subject>Cardiology and Cardiovascular Disease</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - genetics</subject><subject>Case-Control Studies</subject><subject>CHOLESTEROL</subject><subject>Chromatography</subject><subject>Clinical Medicine</subject><subject>Cluster Analysis</subject><subject>Coronary artery</subject><subject>Coronary artery disease</subject><subject>Coronary Artery Disease - blood</subject><subject>Coronary Artery Disease - epidemiology</subject><subject>Coronary Artery Disease - genetics</subject><subject>Coronary vessels</subject><subject>CORONARY-HEART-DISEASE</subject><subject>Disease susceptibility</subject><subject>Endocrinology and Diabetes</subject><subject>Endokrinologi och diabetes</subject><subject>EVENTS</subject><subject>Family medical history</subject><subject>Fatalities</subject><subject>Female</subject><subject>Gene Expression Profiling</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetics</subject><subject>Genomes</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Heart attacks</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Kardiologi</subject><subject>Kardiologi och kardiovaskulära sjukdomar</subject><subject>Klinisk medicin</subject><subject>Lipid composition</subject><subject>Lipids</subject><subject>Lipids - blood</subject><subject>Lipoproteins (low density)</subject><subject>Low density lipoprotein</subject><subject>Low density lipoproteins</subject><subject>Lysophosphatidylcholine</subject><subject>Male</subject><subject>Medical and Health Sciences</subject><subject>Medical research</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicine</subject><subject>Metabolome</subject><subject>Middle Aged</subject><subject>Patient Outcome Assessment</subject><subject>Plasma</subject><subject>POLYMORPHISMS</subject><subject>Population (statistical)</subject><subject>Population studies</subject><subject>PREDICTION</subject><subject>Public Health Surveillance</subject><subject>Regression analysis</subject><subject>Risk</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>SHOTGUN LIPIDOMICS</subject><subject>Species</subject><subject>Sphingomyelin</subject><subject>Statistical analysis</subject><subject>Triglycerides</subject><subject>Wildlife conservation</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><sourceid>DOA</sourceid><recordid>eNqNk21r1TAUx4sobk6_gWhBEH1xr0mT5uGNMIbTwWDi09twmocuM7epTTv125vu3o1VJpgSUk5-59_Tf3KK4ilGa0w4fnMRp6GDsO5jZ9cIcSwou1fsY0mqFasQuX_rfa94lNIFQjURjD0s9ioiGa9qsl8cfwyQNlAG33tT6rjpY_Kjj10JnSkHn76X0ZXGXtoQe9-1pYbB-HgJSU8BhtL4ZCHZx8UDByHZJ7v1oPh6_O7L0YfV6dn7k6PD05UWrB5XrpI1slRyk4cFDI5VtoJaO2YIpgZJ6qTTkgHnSLtaamGlYAJpMRdvyUHxfKvbh5jUzoKkMCWIEs4YycTJljARLlQ_-A0Mv1UEr64CcWgVDKPXwSpHNGZEGM2FpgiaBtdaOgsO8UoaKrLW6VYr_bT91CzUwtTn2eSpklVN0wB2SCrOcaWoNpWSjhCVi3eEAQgCOsut_inXZrkcaq_U8lFWNcr8293PTs3GGm27cYCwSFvudP5ctfFSEU4pZTILvNoJDPHHZNOoNj5pGwJ0Nk6zbRXnVFDMM_riL_Ruc3dUC9k_37mYv6tnUXVIuag4Q3iue30HlR9jN17n6-p8ji8SXi8SMjPaX2MLU0rq5POn_2fPvi3Zl7fYcwthPE8xTPP9TkuQbkE9xJQG625MxkjN3Xbthpq7Te26Lac9u31AN0nX7UX-AOdcJU8</recordid><startdate>20130815</startdate><enddate>20130815</enddate><creator>Fernandez, Celine</creator><creator>Sandin, Marianne</creator><creator>Sampaio, Julio L</creator><creator>Almgren, Peter</creator><creator>Narkiewicz, Krzysztof</creator><creator>Hoffmann, Michal</creator><creator>Hedner, Thomas</creator><creator>Wahlstrand, Björn</creator><creator>Simons, Kai</creator><creator>Shevchenko, Andrej</creator><creator>James, Peter</creator><creator>Melander, Olle</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope><scope>AGCHP</scope><scope>D8T</scope><scope>D95</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20130815</creationdate><title>Plasma lipid composition and risk of developing cardiovascular disease</title><author>Fernandez, Celine ; Sandin, Marianne ; Sampaio, Julio L ; Almgren, Peter ; Narkiewicz, Krzysztof ; Hoffmann, Michal ; Hedner, Thomas ; Wahlstrand, Björn ; Simons, Kai ; Shevchenko, Andrej ; James, Peter ; Melander, Olle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c865t-f2950e497ddddea1af62e2a5cf6d314d094f9fc96a770cf59c8e98680c80053e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Alleles</topic><topic>ARTERY-DISEASE</topic><topic>ASSOCIATION</topic><topic>Biology</topic><topic>BIOMARKERS</topic><topic>Blood cholesterol</topic><topic>BLOOD-PLASMA</topic><topic>Cancer</topic><topic>Cardiac and Cardiovascular Systems</topic><topic>Cardiology and Cardiovascular Disease</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - genetics</topic><topic>Case-Control Studies</topic><topic>CHOLESTEROL</topic><topic>Chromatography</topic><topic>Clinical Medicine</topic><topic>Cluster Analysis</topic><topic>Coronary artery</topic><topic>Coronary artery disease</topic><topic>Coronary Artery Disease - blood</topic><topic>Coronary Artery Disease - epidemiology</topic><topic>Coronary Artery Disease - genetics</topic><topic>Coronary vessels</topic><topic>CORONARY-HEART-DISEASE</topic><topic>Disease susceptibility</topic><topic>Endocrinology and Diabetes</topic><topic>Endokrinologi och diabetes</topic><topic>EVENTS</topic><topic>Family medical history</topic><topic>Fatalities</topic><topic>Female</topic><topic>Gene Expression Profiling</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetics</topic><topic>Genomes</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Heart attacks</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Kardiologi</topic><topic>Kardiologi och kardiovaskulära sjukdomar</topic><topic>Klinisk medicin</topic><topic>Lipid composition</topic><topic>Lipids</topic><topic>Lipids - blood</topic><topic>Lipoproteins (low density)</topic><topic>Low density lipoprotein</topic><topic>Low density lipoproteins</topic><topic>Lysophosphatidylcholine</topic><topic>Male</topic><topic>Medical and Health Sciences</topic><topic>Medical research</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicine</topic><topic>Metabolome</topic><topic>Middle Aged</topic><topic>Patient Outcome Assessment</topic><topic>Plasma</topic><topic>POLYMORPHISMS</topic><topic>Population (statistical)</topic><topic>Population studies</topic><topic>PREDICTION</topic><topic>Public Health Surveillance</topic><topic>Regression analysis</topic><topic>Risk</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>SHOTGUN LIPIDOMICS</topic><topic>Species</topic><topic>Sphingomyelin</topic><topic>Statistical analysis</topic><topic>Triglycerides</topic><topic>Wildlife conservation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fernandez, Celine</creatorcontrib><creatorcontrib>Sandin, Marianne</creatorcontrib><creatorcontrib>Sampaio, Julio L</creatorcontrib><creatorcontrib>Almgren, Peter</creatorcontrib><creatorcontrib>Narkiewicz, Krzysztof</creatorcontrib><creatorcontrib>Hoffmann, Michal</creatorcontrib><creatorcontrib>Hedner, Thomas</creatorcontrib><creatorcontrib>Wahlstrand, Björn</creatorcontrib><creatorcontrib>Simons, Kai</creatorcontrib><creatorcontrib>Shevchenko, Andrej</creatorcontrib><creatorcontrib>James, Peter</creatorcontrib><creatorcontrib>Melander, Olle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><collection>SWEPUB Lunds universitet full text</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Lunds universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fernandez, Celine</au><au>Sandin, Marianne</au><au>Sampaio, Julio L</au><au>Almgren, Peter</au><au>Narkiewicz, Krzysztof</au><au>Hoffmann, Michal</au><au>Hedner, Thomas</au><au>Wahlstrand, Björn</au><au>Simons, Kai</au><au>Shevchenko, Andrej</au><au>James, Peter</au><au>Melander, Olle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma lipid composition and risk of developing cardiovascular disease</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-08-15</date><risdate>2013</risdate><volume>8</volume><issue>8</issue><spage>e71846</spage><epage>e71846</epage><pages>e71846-e71846</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Screening of the fasted plasma lipidome was performed by top-down shotgun analysis and lipidome compositions compared between incident CVD cases (n = 211) and controls (n = 216) from the prospective population-based MDC study using logistic regression adjusting for Framingham risk factors. Associations with incident CVD were seen for eight lipid species (0.21≤q≤0.23). Each standard deviation unit higher baseline levels of two lysophosphatidylcholine species (LPC), LPC16∶0 and LPC20∶4, was associated with a decreased risk for CVD (P = 0.024-0.028). Sphingomyelin (SM) 38∶2 was associated with increased odds of CVD (P = 0.057). Five triglyceride (TAG) species were associated with protection (P = 0.031-0.049). LPC16∶0 was negatively correlated with the carotid intima-media thickness (P = 0.010) and with HbA1c (P = 0.012) whereas SM38∶2 was positively correlated with LDL-cholesterol (P = 0.0*10(-6)) and the q-values were good (q≤0.03). The risk allele of 8 CAD-associated gene variants showed significant association with the plasma level of several lipid species. However, the q-values were high for many of the associations (0.015≤q≤0.75). Risk allele carriers of 3 CAD-loci had reduced level of LPC16∶0 and/or LPC 20∶4 (P≤0.056). Our study suggests that CVD development is preceded by reduced levels of LPC16∶0, LPC20∶4 and some specific TAG species and by increased levels of SM38∶2. It also indicates that certain lipid species are intermediate phenotypes between genetic susceptibility and overt CVD. But it is a preliminary study that awaits replication in a larger population because statistical significance was lost for the associations between lipid species and future cardiovascular events when correcting for multiple testing.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23967253</pmid><doi>10.1371/journal.pone.0071846</doi><tpages>e71846</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2013-08, Vol.8 (8), p.e71846-e71846
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1430437663
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SWEPUB Freely available online; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Aged
Alleles
ARTERY-DISEASE
ASSOCIATION
Biology
BIOMARKERS
Blood cholesterol
BLOOD-PLASMA
Cancer
Cardiac and Cardiovascular Systems
Cardiology and Cardiovascular Disease
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - blood
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - genetics
Case-Control Studies
CHOLESTEROL
Chromatography
Clinical Medicine
Cluster Analysis
Coronary artery
Coronary artery disease
Coronary Artery Disease - blood
Coronary Artery Disease - epidemiology
Coronary Artery Disease - genetics
Coronary vessels
CORONARY-HEART-DISEASE
Disease susceptibility
Endocrinology and Diabetes
Endokrinologi och diabetes
EVENTS
Family medical history
Fatalities
Female
Gene Expression Profiling
Genetic aspects
Genetic Predisposition to Disease
Genetics
Genomes
Health risk assessment
Health risks
Heart attacks
Heart diseases
Humans
Hypertension
Kardiologi
Kardiologi och kardiovaskulära sjukdomar
Klinisk medicin
Lipid composition
Lipids
Lipids - blood
Lipoproteins (low density)
Low density lipoprotein
Low density lipoproteins
Lysophosphatidylcholine
Male
Medical and Health Sciences
Medical research
Medicin och hälsovetenskap
Medicine
Metabolome
Middle Aged
Patient Outcome Assessment
Plasma
POLYMORPHISMS
Population (statistical)
Population studies
PREDICTION
Public Health Surveillance
Regression analysis
Risk
Risk analysis
Risk Factors
SHOTGUN LIPIDOMICS
Species
Sphingomyelin
Statistical analysis
Triglycerides
Wildlife conservation
title Plasma lipid composition and risk of developing cardiovascular disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20lipid%20composition%20and%20risk%20of%20developing%20cardiovascular%20disease&rft.jtitle=PloS%20one&rft.au=Fernandez,%20Celine&rft.date=2013-08-15&rft.volume=8&rft.issue=8&rft.spage=e71846&rft.epage=e71846&rft.pages=e71846-e71846&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0071846&rft_dat=%3Cgale_plos_%3EA478276010%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1430437663&rft_id=info:pmid/23967253&rft_galeid=A478276010&rft_doaj_id=oai_doaj_org_article_f3c1638dc78c40abb15c9feaf0729d48&rfr_iscdi=true